Research programme: anti-CXCL10 antibodies - Stelic Institute
Latest Information Update: 16 Jul 2016
At a glance
- Originator Stelic Institute & Co
- Class
- Mechanism of Action Chemokine receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Liver failure
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Liver-failure in Japan (Injection)
- 27 Oct 2006 Preclinical trials in Liver failure in Japan (Injection)